Peroxisome proliferator-activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axisLiang Qin, Hui Liao|Molecular Medicine Reports|2014Cited by 38
Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathwayLiang Qin, Hui Liao|Molecular Medicine Reports|2014Cited by 28